Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR3 | Q9UBY5 | 6/20 | 0.50 |
| ▸ | LPAR2 | Q9HBW0 | 4/20 | 0.50 |
| ▸ | FDPS | P14324 | 10/20 | 0.44 |
| ▸ | GGPS1 | O95749 | 7/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hexane SCHEMBL28413977 | 0.97 | LPAR3 (0.52) | LPAR3LPAR2FDPSTSHRTHRB | |
| Hexane SCHEMBL3128124 | 0.97 | LPAR3 (0.52) | LPAR3LPAR2FDPSTSHRTHRB | |
| SCHEMBL28533054 | 0.93 | LPAR3 (0.56) | LPAR3LPAR2FDPSGGPS1TSHR | |
| Tridecane SCHEMBL5319320 | 0.93 | LPAR3 (0.56) | LPAR3LPAR2FDPSGGPS1TSHR | |
| SCHEMBL29164627 | 0.93 | LPAR3 (0.56) | LPAR3LPAR2FDPSGGPS1TSHR | |
| Dodecane SCHEMBL28904661 | 0.93 | LPAR3 (0.56) | LPAR3LPAR2FDPSGGPS1TSHR | |
| Hexane SCHEMBL6700386 | 0.93 | LPAR3 (0.55) | LPAR3LPAR2FDPSTSHRTHRB | |
| Hexane SCHEMBL1975489 | 0.93 | LPAR3 (0.55) | LPAR3LPAR2FDPSTSHRTHRB | |
| Hexane SCHEMBL6700086 | 0.93 | LPAR3 (0.55) | LPAR3LPAR2FDPSTSHRTHRB | |
| Hexane SCHEMBL1971634 | 0.93 | LPAR3 (0.55) | LPAR3LPAR2FDPSTSHRTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12552980-B2 | Oil soluble molybdenum complexes as high temperature fouling inhibitors | ECOLAB USA INC (US) | 2026-02-17 | — | — | US | claimed |
| US-11767596-B2 | Oil soluble molybdenum complexes for inhibiting high temperature corrosion and related applications in petroleum refineries | ECOLAB USA INC. (US) | 2023-09-26 | — | — | US | claimed |
| US-11697756-B2 | Oil soluble molybdenum complexes as high temperature fouling inhibitors | ECOLAB USA INC. (US) | 2023-07-11 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12552980-B2 | Oil soluble molybdenum complexes as high temperature fouling inhibitors | DSG1, SLC40A1, SLC9A5 | LPAR3 4768/4885LPAR2 4615/4885FDPS 88/4885 |
| US-11697756-B2 | Oil soluble molybdenum complexes as high temperature fouling inhibitors | NOTUM, FDFT1, MGLL | LPAR3 4759/4885LPAR2 4730/4885FDPS 76/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.